- Home
- Publications
- Publication Search
- Publication Details
Title
Chemotherapy-induced peripheral neurotoxicity: A critical analysis
Authors
Keywords
-
Journal
CA-A CANCER JOURNAL FOR CLINICIANS
Volume 63, Issue 6, Pages 419-437
Publisher
American Cancer Society
Online
2013-11-11
DOI
10.3322/caac.21204
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Neuropathies of Waldenström's Macroglobulinemia (WM) and IgM-MGUS
- (2014) Christopher J. Klein et al. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
- Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS)
- (2013) D. Binda et al. EUROPEAN JOURNAL OF CANCER
- Paclitaxel drug delivery systems
- (2013) Zhiping Zhang et al. Expert Opinion on Drug Delivery
- Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy
- (2013) Ellen M. Lavoie Smith et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Chemotherapy-Induced Neuropathy and Its Association With Quality of Life Among 2- to 11-Year Colorectal Cancer Survivors: Results From the Population-Based PROFILES Registry
- (2013) Floortje Mols et al. JOURNAL OF CLINICAL ONCOLOGY
- Effects of eribulin, vincristine, paclitaxel and ixabepilone on fast axonal transport and kinesin-1 driven microtubule gliding: Implications for chemotherapy-induced peripheral neuropathy
- (2013) Nichole E. LaPointe et al. NEUROTOXICOLOGY
- Paraneoplastic disorders of the peripheral nervous system
- (2013) Jean-Christophe Antoine et al. PRESSE MEDICALE
- Assessing patient-reported peripheral neuropathy: the reliability and validity of the European Organization for Research and Treatment of Cancer QLQ-CIPN20 Questionnaire
- (2013) Ellen M. Lavoie Smith et al. QUALITY OF LIFE RESEARCH
- Falls and functional impairments in cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study
- (2013) J. S. Gewandter et al. SUPPORTIVE CARE IN CANCER
- POEMS syndrome: Update on diagnosis, risk-stratification, and management
- (2012) Angela Dispenzieri AMERICAN JOURNAL OF HEMATOLOGY
- Ca/Mg infusions for the prevention of oxaliplatin-related neurotoxicity in patients with colorectal cancer: a meta-analysis
- (2012) F. Wen et al. ANNALS OF ONCOLOGY
- Peripheral neurotoxicity of oxaliplatin in combination with 5-fluorouracil (FOLFOX) or capecitabine (XELOX): a prospective evaluation of 150 colorectal cancer patients
- (2012) A. A. Argyriou et al. ANNALS OF ONCOLOGY
- The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings
- (2012) G. Cavaletti et al. ANNALS OF ONCOLOGY
- Oxaliplatin/capecitabine vs oxaliplatin/infusional 5-FU in advanced colorectal cancer: the MRC COIN trial
- (2012) A Madi et al. BRITISH JOURNAL OF CANCER
- Long-term neurotoxicity effects of oxaliplatin added to fluorouracil and leucovorin as adjuvant therapy for colon cancer: Results from National Surgical Adjuvant Breast and Bowel Project trials C-07 and LTS-01
- (2012) Kelley M. Kidwell et al. CANCER
- A prospective surveillance model for physical rehabilitation of women with breast cancer
- (2012) Michael D. Stubblefield et al. CANCER
- Clinical pattern and associations of oxaliplatin acute neurotoxicity
- (2012) Andreas A. Argyriou et al. CANCER
- Further data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy
- (2012) Brandi N. Reeves et al. CANCER
- Bortezomib-induced severe autonomic neuropathy
- (2012) A. Stratogianni et al. CLINICAL AUTONOMIC RESEARCH
- Vincristine-Related Neuropathy Versus Acute Inflammatory Demyelinating Polyradiculoneuropathy in Children With Acute Lymphoblastic Leukemia
- (2012) Francesco Brigo et al. JOURNAL OF CHILD NEUROLOGY
- Recommendations for Incorporating Patient-Reported Outcomes Into Clinical Comparative Effectiveness Research in Adult Oncology
- (2012) Ethan Basch et al. JOURNAL OF CLINICAL ONCOLOGY
- Taxane-induced peripheral neuropathy has good long-term prognosis: a 1- to 13-year evaluation
- (2012) Karima Osmani et al. JOURNAL OF NEUROLOGY
- Guillain–Barré Syndrome
- (2012) Nobuhiro Yuki et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anticancer drug oxaliplatin induces acute cooling-aggravated neuropathy via sodium channel subtype NaV1.6-resurgent and persistent current
- (2012) R. Sittl et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The relationship between numbness, tingling, and shooting/burning pain in patients with chemotherapy-induced peripheral neuropathy (CIPN) as measured by the EORTC QLQ-CIPN20 instrument, N06CA
- (2012) Sherry L. Wolf et al. SUPPORTIVE CARE IN CANCER
- Taxane-induced peripheral neuropathy and health-related quality of life in postoperative breast cancer patients undergoing adjuvant chemotherapy: N-SAS BC 02, a randomized clinical trial
- (2012) Kojiro Shimozuma et al. SUPPORTIVE CARE IN CANCER
- Impact of oxaliplatin-induced neuropathy: a patient perspective
- (2012) Barbara K. Bennett et al. SUPPORTIVE CARE IN CANCER
- Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trial
- (2011) J. P. Durand et al. ANNALS OF ONCOLOGY
- Polymorphic markers associated with severe oxaliplatin-induced, chronic peripheral neuropathy in colon cancer patients
- (2011) Hong-Hee Won et al. CANCER
- Comparison of weekly versus every 3 weeks paclitaxel in the treatment of advanced solid tumors: A meta-analysis
- (2011) Ta-Chen Huang et al. CANCER TREATMENT REVIEWS
- An Update on Monoclonal Gammopathy and Neuropathy
- (2011) Sindhu Ramchandren et al. Current Neurology and Neuroscience Reports
- Weekly docetaxel in metastatic breast cancer patients: No superior benefits compared to three-weekly docetaxel
- (2011) Carolien P. Schröder et al. EUROPEAN JOURNAL OF CANCER
- Retrospective study of the impact of pharmacogenetic variants on paclitaxel toxicity and survival in patients with ovarian cancer
- (2011) Troels K. Bergmann et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Low-dose vs. high-dose thalidomide for advanced multiple myeloma: a prospective trial from the Intergroupe Francophone du Myélome
- (2011) Ibrahim Yakoub-Agha et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Neuropathy and paraproteins: review of a complex association
- (2011) Y. A. Rajabally EUROPEAN JOURNAL OF NEUROLOGY
- Thalidomide versus dexamethasone for the treatment of relapsed and/or refractory multiple myeloma: results from OPTIMUM, a randomized trial
- (2011) M. Kropff et al. HAEMATOLOGICA
- Discrepancy between the NCI-CTCAE and DEB-NTC scales in the evaluation of oxaliplatin-related neurotoxicity in patients with metastatic colorectal cancer
- (2011) Naohiko Inoue et al. International Journal of Clinical Oncology
- Paclitaxel-induced peripheral neuropathy in patients receiving adjuvant chemotherapy for breast cancer
- (2011) Yuko Tanabe et al. International Journal of Clinical Oncology
- Genetic Factors Underlying the Risk of Thalidomide-Related Neuropathy in Patients With Multiple Myeloma
- (2011) David C. Johnson et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of Long-Term Serum Platinum Concentrations on Neuro- and Ototoxicity in Cisplatin-Treated Survivors of Testicular Cancer
- (2011) Mette Sprauten et al. JOURNAL OF CLINICAL ONCOLOGY
- Follow-Up Psychophysical Studies in Bortezomib-Related Chemoneuropathy Patients
- (2011) Jessica A. Boyette-Davis et al. JOURNAL OF PAIN
- Use of Patient-Reported Outcomes to Improve the Predictive Accuracy of Clinician-Reported Adverse Events
- (2011) E. Basch et al. JNCI-Journal of the National Cancer Institute
- Chemotherapy-induced peripheral neurotoxicity can be misdiagnosed by the National Cancer Institute Common Toxicity scale
- (2011) Barbara Frigeni et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics
- (2011) Guido Cavaletti et al. LANCET ONCOLOGY
- Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial
- (2011) Richard A Adams et al. LANCET ONCOLOGY
- Prevalence of peripheral neuropathy in multiple myeloma at initial diagnosis
- (2011) Pankaj Malhotra et al. LEUKEMIA & LYMPHOMA
- Adverse interactions between antifungal azoles and vincristine: review and analysis of cases
- (2011) Brad Moriyama et al. MYCOSES
- Longitudinal assessment of oxaliplatin-induced neuropathy
- (2011) A. Z. Burakgazi et al. NEUROLOGY
- Long-Term Neuropathy After Oxaliplatin Treatment: Challenging the Dictum of Reversibility
- (2011) S. B. Park et al. ONCOLOGIST
- Reintroduction of Oxaliplatin: A Viable Approach to the Long-Term Management of Metastatic Colorectal Cancer
- (2011) Axel Grothey ONCOLOGY
- Assessing the impact of chemotherapy-induced peripheral neurotoxicity on the quality of life of cancer patients
- (2011) C. M. L. Driessen et al. SUPPORTIVE CARE IN CANCER
- Paraneoplastic Neurologic Syndrome in the PNS Euronetwork Database
- (2010) Bruno Giometto ARCHIVES OF NEUROLOGY
- Once- versus twice-weekly bortezomib induction therapy with CyBorD in newly diagnosed multiple myeloma
- (2010) C. B. Reeder et al. BLOOD
- Efficacy and safety of once-weekly bortezomib in multiple myeloma patients
- (2010) S. Bringhen et al. BLOOD
- Association between patient reported outcomes and quantitative sensory tests for measuring long-term neurotoxicity in breast cancer survivors treated with adjuvant paclitaxel chemotherapy
- (2010) Dawn L. Hershman et al. BREAST CANCER RESEARCH AND TREATMENT
- A randomized phase 2 trial comparing 3-hour versus 96-hour infusion schedules of paclitaxel for the treatment of metastatic breast cancer
- (2010) Stacy L. Moulder et al. CANCER
- The Reliability and Validity of a Modified Total Neuropathy Score-Reduced and Neuropathic Pain Severity Items When Used to Measure Chemotherapy-Induced Peripheral Neuropathy in Patients Receiving Taxanes and Platinums
- (2010) Ellen M. Lavoie Smith et al. CANCER NURSING
- Proteasome inhibitors increase tubulin polymerization and stabilization in tissue culture cells: A possible mechanism contributing to peripheral neuropathy and cellular toxicity following proteasome inhibition
- (2010) Marianne S. Poruchynsky et al. CELL CYCLE
- Chemotherapy-Induced Peripheral Neurotoxicity assessment: A critical revision of the currently available tools
- (2010) Guido Cavaletti et al. EUROPEAN JOURNAL OF CANCER
- Risk factors for, and reversibility of, peripheral neuropathy associated with bortezomib-melphalan-prednisone in newly diagnosed patients with multiple myeloma: subanalysis of the phase 3 VISTA study
- (2010) Meletios A. Dimopoulos et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Screening for tumours in paraneoplastic syndromes: report of an EFNS Task Force
- (2010) M. J. Titulaer et al. EUROPEAN JOURNAL OF NEUROLOGY
- Patient-reported peripheral neuropathy of doxorubicin and cisplatin with and without paclitaxel in the treatment of advanced endometrial cancer: Results from GOG 184
- (2010) David Cella et al. GYNECOLOGIC ONCOLOGY
- Pharmacogenetic Predictors of Adverse Events and Response to Chemotherapy in Metastatic Colorectal Cancer: Results From North American Gastrointestinal Intergroup Trial N9741
- (2010) Howard L. McLeod et al. JOURNAL OF CLINICAL ONCOLOGY
- Pharmacogenetic Assessment of Toxicity and Outcome in Patients With Metastatic Colorectal Cancer Treated With LV5FU2, FOLFOX, and FOLFIRI: FFCD 2000-05
- (2010) Valérie Boige et al. JOURNAL OF CLINICAL ONCOLOGY
- Intravenous Calcium and Magnesium for Oxaliplatin-Induced Sensory Neurotoxicity in Adjuvant Colon Cancer: NCCTG N04C7
- (2010) Axel Grothey et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparison of Two Standard Chemotherapy Regimens for Good-Prognosis Germ Cell Tumors: Updated Analysis of a Randomized Trial
- (2010) Peter S. Grimison et al. JNCI-Journal of the National Cancer Institute
- Measures of chemotherapy-induced peripheral neuropathy: a systematic review of psychometric properties
- (2010) Kathleen A. Griffith et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial
- (2010) Annemiek Broyl et al. LANCET ONCOLOGY
- Treatment-related peripheral neuropathy in multiple myeloma: the challenge continues
- (2010) Michel Delforge et al. LANCET ONCOLOGY
- Vitamin E neuroprotection for cisplatin neuropathy: A randomized, placebo-controlled trial
- (2010) A. Pace et al. NEUROLOGY
- Acute onset flaccid quadriparesis in pediatric non-Hodgkin lymphoma: Vincristine induced or Guillain-Barré syndrome?
- (2010) Ankur Bahl et al. PEDIATRIC BLOOD & CANCER
- Increased risk of vincristine neurotoxicity associated with low CYP3A5 expression genotype in children with acute lymphoblastic leukemia
- (2010) Akinbode Egbelakin et al. PEDIATRIC BLOOD & CANCER
- Polymorphisms in cytochromes P450 2C8 and 3A5 are associated with paclitaxel neurotoxicity
- (2010) S Leskelä et al. PHARMACOGENOMICS JOURNAL
- Persistent Mobility Disability After Neurotoxic Chemotherapy
- (2010) Elizabeth S. Hile et al. PHYSICAL THERAPY
- Chemotherapy-related polyneuropathy may deteriorate quality of life in patients with B-cell lymphoma
- (2010) Byung-Jo Kim et al. QUALITY OF LIFE RESEARCH
- The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial
- (2010) Lisa A. Kottschade et al. SUPPORTIVE CARE IN CANCER
- Persistent neuropathy after treatment with cisplatin and oxaliplatin
- (2009) Elke E. M. Brouwers et al. ACTA ONCOLOGICA
- Clinician versus nurse symptom reporting using the National Cancer Institute--Common Terminology Criteria for Adverse Events during chemotherapy: results of a comparison based on patient's self-reported questionnaire
- (2009) M. Cirillo et al. ANNALS OF ONCOLOGY
- Lenalidomide plus dexamethasone versus thalidomide plus dexamethasone in newly diagnosed multiple myeloma: a comparative analysis of 411 patients
- (2009) F. Gay et al. BLOOD
- Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy
- (2009) Susanna B. Park et al. BRAIN
- Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: impact of a dose-modification guideline
- (2009) Paul G. Richardson et al. BRITISH JOURNAL OF HAEMATOLOGY
- Vincristine sulfate liposomes injection (Marqibo) in heavily pretreated patients with refractory aggressive non-Hodgkin lymphoma
- (2009) M. A. Rodriguez et al. CANCER
- Overall survival benefit for weekly vs. three-weekly taxanes regimens in advanced breast cancer: A meta-analysis
- (2009) Davide Mauri et al. CANCER TREATMENT REVIEWS
- Pharmacogenetic Analyses of a Phase III Trial in Metastatic Gastroesophageal Adenocarcinoma With Fluorouracil and Leucovorin Plus Either Oxaliplatin or Cisplatin: A Study of the Arbeitsgemeinschaft Internistische Onkologie
- (2009) Eray Goekkurt et al. JOURNAL OF CLINICAL ONCOLOGY
- Acute Abnormalities of Sensory Nerve Function Associated With Oxaliplatin-Induced Neurotoxicity
- (2009) Susanna B. Park et al. JOURNAL OF CLINICAL ONCOLOGY
- Significantly Longer Progression-Free Survival Withnab-Paclitaxel Compared With Docetaxel As First-Line Therapy for Metastatic Breast Cancer
- (2009) William J. Gradishar et al. JOURNAL OF CLINICAL ONCOLOGY
- Single-Agent Bortezomib in Previously Untreated Multiple Myeloma: Efficacy, Characterization of Peripheral Neuropathy, and Molecular Correlations With Response and Neuropathy
- (2009) Paul G. Richardson et al. JOURNAL OF CLINICAL ONCOLOGY
- Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial
- (2009) Thierry André et al. JOURNAL OF CLINICAL ONCOLOGY
- Observational Study of Prevalence of Long-term Raynaud-Like Phenomena and Neurological Side Effects in Testicular Cancer Survivors
- (2009) M. Brydoy et al. JNCI-Journal of the National Cancer Institute
- Role of a pre-existing neuropathy on the course of bortezomib-induced peripheral neurotoxicity
- (2009) Francesca Lanzani et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- Peripheral neuropathy in survivors of childhood acute lymphoblastic leukemia
- (2009) Sindhu Ramchandren et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- Bortezomib Induces the Formation of Nuclear poly(A) RNA Granules Enriched in Sam68 and PABPN1 in Sensory Ganglia Neurons
- (2009) Iñigo Casafont et al. NEUROTOXICITY RESEARCH
- Thermal hyperalgesia as a marker of oxaliplatin neurotoxicity: A prospective quantified sensory assessment study
- (2009) N. Attal et al. PAIN
- Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02
- (2009) Kojiro Shimozuma et al. SUPPORTIVE CARE IN CANCER
- Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority study
- (2008) M. L. Rothenberg et al. ANNALS OF ONCOLOGY
- A randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer
- (2008) G. Fountzilas et al. BREAST CANCER RESEARCH AND TREATMENT
- Phase 3 study comparing the use of docetaxel on an every-3-week versus weekly schedule in the treatment of metastatic breast cancer
- (2008) Edgardo Rivera et al. CANCER
- Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy
- (2008) Ravi D. Rao et al. CANCER
- Immune-mediated neuropathies in myeloma patients treated with bortezomib
- (2008) Sabrina Ravaglia et al. CLINICAL NEUROPHYSIOLOGY
- Peripheral nerve damage associated with administration of taxanes in patients with cancer
- (2008) Andreas A. Argyriou et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Chemotherapy-induced peripheral neuropathy: Prevention and treatment strategies
- (2008) Sherry Wolf et al. EUROPEAN JOURNAL OF CANCER
- Glutathione-S-transferase pi (GSTP1) codon 105 polymorphism is not associated with oxaliplatin efficacy or toxicity in advanced colorectal cancer patients
- (2008) Dina M. Kweekel et al. EUROPEAN JOURNAL OF CANCER
- Oxaliplatin-Related Neurotoxicity: Interest of Calcium-Magnesium Infusion and No Impact on Its Efficacy
- (2008) Laurence Gamelin et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase III Trial of Weekly Compared With Every-3-Weeks Paclitaxel for Metastatic Breast Cancer, With Trastuzumab for all HER-2 Overexpressors and Random Assignment to Trastuzumab or Not in HER-2 Nonoverexpressors: Final Results of Cancer and Leukemia Group B Protocol 9840
- (2008) Andrew D. Seidman et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase III Trial Comparing Retroperitoneal Lymph Node Dissection With One Course of Bleomycin and Etoposide Plus Cisplatin Chemotherapy in the Adjuvant Treatment of Clinical Stage I Nonseminomatous Testicular Germ Cell Tumors: AUO Trial AH 01/94 by the German Testicular Cancer Study Group
- (2008) Peter Albers et al. JOURNAL OF CLINICAL ONCOLOGY
- Thalidomide and sensory neurotoxicity: a neurophysiological study
- (2008) G Zara et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies
- (2008) J Honnorat et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Weekly Paclitaxel in the Adjuvant Treatment of Breast Cancer
- (2008) Joseph A. Sparano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neuropathy in lymphoma: a relationship between the pattern of neuropathy, type of lymphoma and prognosis?
- (2007) K Viala et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started